Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia.

Miodownik C, Meoded A, Libov I, Bersudsky Y, Sela BA, Lerner V.

Clin Neuropharmacol. 2008 Jul-Aug;31(4):197-203. doi: 10.1097/WNF.0b013e3181506623.

PMID:
18670243
2.

High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia.

Lerner V, Miodownik C, Kaptsan A, Vishne T, Sela BA, Levine J.

J Clin Psychiatry. 2005 Dec;66(12):1558-63.

PMID:
16401157
3.

Serum vitamin B6 in schizophrenic and schizoaffective patients with and without tardive dyskinesia.

Miodownik C, Lerner V, Cohen H, Kotler M.

Clin Neuropharmacol. 2000 Jul-Aug;23(4):212-5.

PMID:
11020126
4.

High plasma clozapine levels in tardive dyskinesia.

Pollack S, Lieberman J, Kleiner D, Szymanski S, Kane J, Borenstein M, Cooper T.

Psychopharmacol Bull. 1993;29(2):257-62.

PMID:
8290674
5.

High-dose vitamin B6 decreases homocysteine serum levels in patients with schizophrenia and schizoaffective disorders: a preliminary study.

Miodownik C, Lerner V, Vishne T, Sela BA, Levine J.

Clin Neuropharmacol. 2007 Jan-Feb;30(1):13-7.

PMID:
17272965
6.

Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.

Muscettola G, Barbato G, de Bartolomeis A, Monteleone P, Pickar D.

Psychiatry Res. 1990 Sep;33(3):259-67.

PMID:
2243901
7.

Tardive dyskinesia and impaired glucose tolerance.

Chong SA, Mythily, Lum A, Huak CY, Kane J.

Hum Psychopharmacol. 2002 Aug;17(6):305-7.

PMID:
12404676
8.
9.

Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia.

Monteleone P, Maj M, Ariano MG, Iovino M, Fiorenza L, Steardo L.

Psychopharmacology (Berl). 1988;96(2):223-6.

PMID:
3148149
10.

[Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders].

Miodownik C, Cohen H, Kotler M, Lerner V.

Harefuah. 2003 Sep;142(8-9):592-6, 647. Hebrew.

PMID:
14518160
12.
13.
14.

[Pro- and antioxidant processes in schizophrenics with tardive dyskinesia].

GaƂecki P, Pietras T, Florkowki A.

Psychiatr Pol. 2005 Nov-Dec;39(6):1131-41. Polish.

PMID:
16526180
15.

Relationship of symptomatology of schizophrenia and tardive dyskinesia.

Perenyi A, Norman T, Burrows GD.

Eur Neuropsychopharmacol. 1992 Mar;2(1):51-5.

PMID:
1638174
16.

Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia.

Brown K, Reid A, White T, Henderson T, Hukin S, Johnstone C, Glen A.

Biol Psychiatry. 1998 Jun 15;43(12):863-7.

PMID:
9627739
17.

Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women.

Richardson MA, Reilly MA, Read LL, Flynn CJ, Suckow RF, Maher TJ, Sziraki I.

Psychopharmacology (Berl). 1999 Apr;143(4):347-57.

PMID:
10367551
18.

Plasma pyridoxal 5'-phosphate is a significant indicator of immune responses in the mechanically ventilated critically ill.

Huang YC, Chang HH, Huang SC, Cheng CH, Lee BJ, Cheng SY, Su KH.

Nutrition. 2005 Jul-Aug;21(7-8):779-85.

PMID:
15975484
19.

Memory impairment in schizophrenic patients with tardive dyskinesia.

Sorokin JE, Giordani B, Mohs RC, Losonczy MF, Davidson M, Siever LJ, Ryan TA, Davis KL.

Biol Psychiatry. 1988 Jan 15;23(2):129-35.

PMID:
3334882
20.

Mortality rate of schizophrenic patients with tardive dyskinesia during 10 years: a controlled study.

Yagi G, Takamiya M, Kanba S, Kamijima K.

Keio J Med. 1989 Mar;38(1):70-2.

Items per page

Supplemental Content

Write to the Help Desk